Figure 3.
UBE2L3 and LUBAC Augment Late-Phase NF-κB Activation in Response to TNF
(A) Increased production of LUBAC in combination with UBE2L3 augments NF-κB activation after 10 hr of TNF stimulation. This augmentation of the TNF response is abrogated by variant p.Cys86Ser UBE2L3 or variant p.Cys885Ser HOIP.
(B) Time course showing NF-κB activation after TNF stimulation in response to increased synthesis of LUBAC and UBE2L3. Maximal dysregulation of NF-κB occurs in the late-phase response to TNF. Error bars represent standard error of the mean.